X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (83) 83
index medicus (77) 77
humans (62) 62
lung cancer (55) 55
mutation (40) 40
cancer (35) 35
open-label (34) 34
chemotherapy (33) 33
lung neoplasms - genetics (33) 33
lung neoplasms - drug therapy (32) 32
respiratory system (32) 32
review (32) 32
immunotherapy (27) 27
carcinoma, non-small-cell lung - genetics (26) 26
resistance (26) 26
carcinoma, non-small-cell lung - drug therapy (25) 25
female (25) 25
male (23) 23
medicine, research & experimental (22) 22
gefitinib (21) 21
middle aged (21) 21
neoplasms. tumors. oncology. including cancer and carcinogens (21) 21
aged (20) 20
non-small cell lung cancer (20) 20
nsclc (19) 19
genetic aspects (17) 17
review article (17) 17
care and treatment (16) 16
lung cancer, non-small cell (16) 16
melanoma (16) 16
acquired-resistance (15) 15
adult (15) 15
tumors (15) 15
1st-line treatment (14) 14
aged, 80 and over (14) 14
erlotinib (14) 14
mutations (14) 14
receptor, epidermal growth factor - genetics (14) 14
adenocarcinoma (13) 13
cancer therapies (13) 13
cell lung-cancer (13) 13
lung neoplasms - pathology (13) 13
non-small cell lung carcinoma (13) 13
prognosis (13) 13
protein kinase inhibitors - therapeutic use (13) 13
survival (13) 13
activation (12) 12
animals (12) 12
antineoplastic agents - therapeutic use (12) 12
health aspects (12) 12
metastasis (12) 12
docetaxel (11) 11
kinases (11) 11
trial (11) 11
tyrosine kinase inhibitors (11) 11
antineoplastic combined chemotherapy protocols - therapeutic use (10) 10
crizotinib (10) 10
editorial (10) 10
growth-factor receptor (10) 10
research (10) 10
respiratory tract diseases (10) 10
treatment outcome (10) 10
article (9) 9
biomarkers (9) 9
carcinoma, non-small-cell lung - pathology (9) 9
drug resistance, neoplasm (9) 9
egfr (9) 9
epidermal growth factor receptor (9) 9
afatinib (8) 8
anaplastic lymphoma kinase (8) 8
biomarkers, tumor - genetics (8) 8
egfr mutations (8) 8
lung neoplasms - metabolism (8) 8
nivolumab (8) 8
non-small-cell lung cancer (8) 8
phase-iii (8) 8
receptor protein-tyrosine kinases - genetics (8) 8
antitumor-activity (7) 7
braf (7) 7
cell line, tumor (7) 7
circulating tumor-cells (7) 7
cisplatin (7) 7
disease-free survival (7) 7
double-blind (7) 7
expression (7) 7
gene (7) 7
gene mutations (7) 7
genes (7) 7
hemic and lymphatic diseases (7) 7
inhibitors (7) 7
liquid biopsies (7) 7
liquid biopsy (7) 7
protein kinase inhibitors - pharmacology (7) 7
proteins (7) 7
proto-oncogene proteins - genetics (7) 7
targeted therapies (7) 7
analysis (6) 6
biotechnology & applied microbiology (6) 6
cell biology (6) 6
commentary (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of Oncology, ISSN 0923-7534, 10/2017, Volume 28, Issue suppl_9
Journal Article
The Lancet Oncology, ISSN 1470-2045, 10/2017, Volume 18, Issue 10, pp. 1286 - 1287
Journal Article
Lancet Oncology, ISSN 1470-2045, 10/2017, Volume 18, Issue 10, p. 1286
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10026, pp. 1354 - 1356
To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/S0140-6736(15)01125-3 Byline: Rafael Rosell, Niki Karachaliou Author... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | Lung Neoplasms - genetics | Female | Male | Gene Expression Profiling | Carcinoma, Non-Small-Cell Lung - genetics | Humans | Genetic aspects | Diagnosis | Lung cancer | Cancer | Mutation | Kinases | Medical screening | Cancer therapies
Journal Article
癌症生物学与医学:英文版, ISSN 2095-3941, 2015, Volume 12, Issue 2, pp. 74 - 78
In recent years, further understanding of the interaction between the immune system and tumor growth has led to the development of several immunotherapies.... 
特性 | 免疫疗法 | 相互作用 | 肿瘤生长 | 微环境 | 免疫系统激活 | 非小细胞肺癌 | 肿瘤免疫 | MEDICINE, RESEARCH & EXPERIMENTAL | ONCOLOGY | SAFETY | PD-L1 EXPRESSION | ANTIBODY | B7-H1 | BLOCKADE | NIVOLUMAB | CHECKPOINTS
Journal Article
Journal Article
Journal Article
Nature Reviews Clinical Oncology, ISSN 1759-4774, 07/2016, Volume 13, Issue 7, pp. 401 - 402
Journal Article
The Lancet Oncology, ISSN 1470-2045, 11/2018, Volume 19, Issue 11, pp. 1423 - 1424
Journal Article
Therapeutic Advances in Medical Oncology, ISSN 1758-8340, 1/2018, Volume 10, p. 1758834017745012
Treatment for advanced non-small cell lung cancer (NSCLC) has been significantly improved in recent years with the incorporation of drugs targeting... 
Targeted therapy | Advanced NSCLC | Immunotherapy | targeted therapy | 1ST-LINE TREATMENT | MULTICENTER | PHASE-III | OPEN-LABEL | RANDOMIZED CONTROLLED-TRIAL | advanced NSCLC | DURVALUMAB | CHEMOTHERAPY | EGFR MUTANT NSCLC | ONCOLOGY | immunotherapy | MUTATIONAL LANDSCAPE | DOUBLE-BLIND
Journal Article
The Lancet Oncology, ISSN 1470-2045, 03/2018, Volume 19, Issue 3, pp. e126 - e126
Journal Article
Nature Reviews Clinical Oncology, ISSN 1759-4774, 07/2016, Volume 13, Issue 7, pp. 401 - 402
Analysis of circulating tumour DNA (ctDNA) in blood samples provides a surrogate form of tumour biopsy (liquid biopsy) for determining EGFR and KRAS mutation... 
NSCLC | ONCOLOGY | Lung Neoplasms - genetics | Receptor, Epidermal Growth Factor - genetics | ras Proteins - genetics | Proto-Oncogene Proteins - genetics | Mutation | Humans | Lung cancer, Non-small cell | Health aspects | Care and treatment
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 7, pp. 859 - 860
Journal Article
Nature Reviews Clinical Oncology, ISSN 1759-4774, 10/2013, Volume 10, Issue 10, pp. 549 - 550
Two phase III trials have shown that prolonging chemotherapy duration improves outcome in patients with nonsquamous non-small-cell lung cancer. Pemetrexed... 
TRIAL | CISPLATIN | ONCOLOGY | PLUS | Lung Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Humans | Female | Male | Carcinoma, Non-Small-Cell Lung - drug therapy
Journal Article
Nature Reviews Clinical Oncology, ISSN 1759-4774, 02/2015, Volume 12, Issue 2, pp. 75 - 76
In 2014, developments in our understanding of escape signalling circuits implicated in resistance to targeted agents in patients with lung cancer have led to... 
Chemotherapy | Care and treatment | Lung cancer | Genetic aspects | Research | Drug resistance | Health aspects | Risk factors | Cancer
Journal Article
Current Opinion in Oncology, ISSN 1040-8746, 01/2020, Volume 32, Issue 1, pp. 37 - 43
PURPOSE OF REVIEWThe mutational landscape in lung adenocarcinoma (LADC) is broadly recognized, particularly regarding the presence of the epidermal growth... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.